BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34193753)

  • 1. Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified.
    Itami H; Nakamine H; Kubo M; Ogawa K; Tani R; Nakamura S; Takeda M; Nitta Y; Uchiyama T; Fujii T; Hatakeyama K; Ohbayashi C
    J Clin Exp Hematop; 2021 Sep; 61(3):152-161. PubMed ID: 34193753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy.
    Suzuki Y; Kohno K; Matsue K; Sakakibara A; Ishikawa E; Shimada S; Shimada K; Mabuchi S; Takahara T; Kato S; Nakamura S; Satou A
    Cancer Med; 2020 Jul; 9(13):4768-4776. PubMed ID: 32367674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
    Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
    Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
    Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
    Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study.
    Boonsakan P; Iamsumang W; Chantrathammachart P; Chayavichitsilp P; Suchonwanit P; Rutnin S
    Biomed Res Int; 2020; 2020():1350820. PubMed ID: 32566654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.
    Ponzoni M; Ferreri AJ; Campo E; Facchetti F; Mazzucchelli L; Yoshino T; Murase T; Pileri SA; Doglioni C; Zucca E; Cavalli F; Nakamura S
    J Clin Oncol; 2007 Jul; 25(21):3168-73. PubMed ID: 17577023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.
    Saka M; Fujimoto M; Mizoguchi K; Tsujimura M; Saeki M; Hirata M; Shibuya S; Odani K; Sakurai T; Yuba Y; Moriyoshi K; Nakajima N; Sumiyoshi S; Kono F; Ono K; Shirase T; Watanabe C; Yoshizawa A; Haga H
    Am J Surg Pathol; 2024 Jun; 48(6):671-680. PubMed ID: 38497417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity?
    Abe Y; Usui Y; Narita K; Takeuchi M; Matsue K
    Int J Hematol; 2018 Dec; 108(6):637-639. PubMed ID: 30196477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
    Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
    Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.
    Yamaguchi M; Seto M; Okamoto M; Ichinohasama R; Nakamura N; Yoshino T; Suzumiya J; Murase T; Miura I; Akasaka T; Tamaru J; Suzuki R; Kagami Y; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
    Blood; 2002 Feb; 99(3):815-21. PubMed ID: 11806981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagocytosis-Related (Asian Variant) Intravascular Large B-Cell Lymphoma in a Hispanic Patient:  A Case Report Highlighting a Micronodular Pattern in the Spleen.
    Hall JM; Meyers N; Andrews J
    Am J Clin Pathol; 2016 May; 145(5):727-35. PubMed ID: 27247375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
    Murase T; Yamaguchi M; Suzuki R; Okamoto M; Sato Y; Tamaru J; Kojima M; Miura I; Mori N; Yoshino T; Nakamura S
    Blood; 2007 Jan; 109(2):478-85. PubMed ID: 16985183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular large B-cell lymphoma: report of three cases and analysis of the mTOR pathway.
    Shen Q; Duan X; Feng W; Nguyen N; Lapus A; Brown RE; Chen L
    Int J Clin Exp Pathol; 2011; 4(8):782-90. PubMed ID: 22135726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of PD-L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features.
    Gupta GK; Jaffe ES; Pittaluga S
    Histopathology; 2019 Aug; 75(2):282-286. PubMed ID: 30938862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of intravascular large B-cell lymphoma: a single-institute retrospective analysis].
    Okuno T; Iwata S; Hayakawa H; Miyao K; Kajiguchi T
    Rinsho Ketsueki; 2019; 60(3):184-190. PubMed ID: 31068513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
    Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
    Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proposal of possible diagnostic strategy for intravascular large B-cell lymphoma--usefulness of biopsy from senile hemangioma].
    Ishida M; Yoshii M; Yoshida T; Okabe H
    Rinsho Byori; 2012 Mar; 60(3):201-5. PubMed ID: 22568081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular large B-cell lymphoma presenting as cholecystitis and pancytopenia: case report with literature review.
    Duan X; Lapus A; Brown RE; Chen L
    Ann Clin Lab Sci; 2011; 41(3):262-6. PubMed ID: 22075510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.